KATHERINE LANG ROTKER M.D.
Prescription History 1982998548
Urology in New London, CT
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for KATHERINE LANG ROTKER M.D., an active Urology specialist practicing in New London, CT. Our medical registry currently tracks 7 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 222 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 91 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other CT PrescribersVs. CT Avg |
|---|---|---|---|
| Tamsulosin Hcl | 91 | $19.73▼ below CT avg | ≈ Typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2023, this provider wrote 91 Medicare prescriptions for Tamsulosin Hcl, about the same volume as the typical Connecticut prescriber of this medication (88). Medicare paid an average of $19.73 per fill, versus $22.12 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 244 30-Day Fills standardized to 30-day supplies 7,285 Days of Medication total across all patients in 2023 | |||
| Oxybutynin Chloride ErOxybutynin Chloride | 37 | $22.72▼ below CT avg | ≈ Typical |
About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾ It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida). In 2023, this provider wrote 37 Medicare prescriptions for Oxybutynin Chloride Er, about the same volume as the typical Connecticut prescriber of this medication (36). Medicare paid an average of $22.72 per fill, versus $45.68 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 51 30-Day Fills standardized to 30-day supplies 1,522 Days of Medication total across all patients in 2023 | |||
| MyrbetriqMirabegron | 28 | $776.38 | ▼ Less than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. In 2023, this provider wrote 28 Medicare prescriptions for Myrbetriq, about half the volume of the typical Connecticut prescriber of this medication (58). Medicare paid an average of $776.38 per fill, versus $678.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44 30-Day Fills standardized to 30-day supplies 1,316 Days of Medication total across all patients in 2023 | |||
| Finasteride | 22 | $19.26 | ▼ Less than typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2023, this provider wrote 22 Medicare prescriptions for Finasteride, about a third of the volume of the typical Connecticut prescriber of this medication (65). Medicare paid an average of $19.26 per fill, versus $18.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 46 30-Day Fills standardized to 30-day supplies 1,350 Days of Medication total across all patients in 2023 | |||
| Ciprofloxacin Hcl | 17 | $9.23 | ▼ Less than typical |
About Ciprofloxacin Hcl: This medication is used to treat eye infections. Show more ▾ Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A broad-spectrum antimicrobial carboxyfluoroquinoline. In 2023, this provider wrote 17 Medicare prescriptions for Ciprofloxacin Hcl, about 71% of the volume of the typical Connecticut prescriber of this medication (24). Medicare paid an average of $9.23 per fill, versus $8.47 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 99 Days of Medication total across all patients in 2023 | |||
| Testosterone | 16 | $373.81 | ▼ Less than typical |
About Testosterone: This medicated patch contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2023, this provider wrote 16 Medicare prescriptions for Testosterone, about 67% of the volume of the typical Connecticut prescriber of this medication (24). Medicare paid an average of $373.81 per fill, versus $285.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 510 Days of Medication total across all patients in 2023 | |||
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $5.03▼ below CT avg | ▼ Less than typical |
About Sulfamethoxazole-Trimethoprim: This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. Show more ▾ It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. In 2023, this provider wrote 11 Medicare prescriptions for Sulfamethoxazole-Trimethoprim, about half the volume of the typical Connecticut prescriber of this medication (24). Medicare paid an average of $5.03 per fill, versus $6.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average CT prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the CT average for this medication. 11 30-Day Fills standardized to 30-day supplies 85 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for KATHERINE LANG ROTKER M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Urology prescribing approach at this New London, CT practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among CT prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
